Matches in Wikidata for { <http://www.wikidata.org/entity/Q80365569> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q80365569 description "clinical trial" @default.
- Q80365569 description "ensayu clínicu" @default.
- Q80365569 description "klinisch onderzoek" @default.
- Q80365569 description "клінічне випробування" @default.
- Q80365569 name "A Phase IIa Trial of the Oral JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM" @default.
- Q80365569 name "A Phase IIa Trial of the Oral JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM" @default.
- Q80365569 type Item @default.
- Q80365569 label "A Phase IIa Trial of the Oral JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM" @default.
- Q80365569 label "A Phase IIa Trial of the Oral JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM" @default.
- Q80365569 prefLabel "A Phase IIa Trial of the Oral JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM" @default.
- Q80365569 prefLabel "A Phase IIa Trial of the Oral JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult IIM" @default.
- Q80365569 P1050 Q80365569-6CCD1E17-73ED-4F03-BB73-6C1E9BB2C55A @default.
- Q80365569 P1132 Q80365569-A90A445B-6172-48FD-A9D7-6C09F674B1DB @default.
- Q80365569 P1476 Q80365569-ED614AC4-C4BD-4838-A618-46EC61FD7C64 @default.
- Q80365569 P1813 Q80365569-0FCB0236-FE7C-40BC-9038-1D68B0E6F9D9 @default.
- Q80365569 P2899 Q80365569-5B9A88F7-9084-4639-824B-6E8C4B43F6DB @default.
- Q80365569 P3098 Q80365569-0FEC7A76-8EF3-4C51-93EB-0E9072A5BBCC @default.
- Q80365569 P31 Q80365569-DA464D0E-00CD-437C-9F1A-C667713BBB09 @default.
- Q80365569 P580 Q80365569-FABAA8D4-CCDB-47E4-9C6A-0EE4CC66FC8F @default.
- Q80365569 P582 Q80365569-23CA04A0-CC82-41F8-B5DD-20722C11A820 @default.
- Q80365569 P6099 Q80365569-183A785E-6CB1-44DA-8F94-0AC90575DF1C @default.
- Q80365569 P8363 Q80365569-52A42DAC-4D53-4CBA-A279-C0983F3B406C @default.
- Q80365569 P1050 Q1433212 @default.
- Q80365569 P1132 "+25" @default.
- Q80365569 P1476 "A Randomised, Phase IIa Treatment Delayed-start Trial of the Oral JAK 1/2 Inhibitor, Baricitinib, in the Treatment of Adult Idiopathic Inflammatory Myopathy" @default.
- Q80365569 P1813 "MYOJAK" @default.
- Q80365569 P2899 "+18" @default.
- Q80365569 P3098 "NCT04208464" @default.
- Q80365569 P31 Q30612 @default.
- Q80365569 P580 "2020-07-01T00:00:00Z" @default.
- Q80365569 P582 "2022-02-28T00:00:00Z" @default.
- Q80365569 P6099 Q42824440 @default.
- Q80365569 P8363 Q78089383 @default.